Sage oil API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Sage oil is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Sage oil or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Sage oil API 8022-56-8?

Description:
Here you will find a list of producers, manufacturers and distributors of Sage oil. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Sage oil 
Synonyms:
Broadleaf sage oil , Common sage oil , Culinary sage oil , Dalmatian sage oil , Fema no. 3001 , Garden sage oil , Kitchen sage oil , Purple sage oil , Red sage oil , Sage leaf oil , Sage leaf water , Sage oil albania , Sage oil cuba , Sage oil dalmatian , Sage oil england , Sage oil france , Sage oil germany , Sage oil sardinia , Sage oil spanish , Sage oil, dalmatian type , Sage volatile oil , Salvia officinalis (sage) leaf water , Salvia officinalis (sage) oil , Salvia officinalis leaf oil  
Cas Number:
8022-56-8 
DrugBank number:
DB11199 
Unique Ingredient Identifier:
U27K0H1H2O

General Description:

Sage oil, identified by CAS number 8022-56-8, is a notable compound with significant therapeutic applications. Sage oil is extracted from sage or *Salvia officinalis*, the herb commonly used for culinary purposes. *Salvia officinalis* is a common sage and a member of the genus *Salvia*, that includes aromatic and perennial plants with flowers. Essential oil has been traditionally used in medicine for the relief of pain and the treatment of inflammation and infections, as it is reported to exhibit carminative, antispasmodic, antiseptic, and astringent properties . The main constituents of sage oil include camphor, 1,8-cineole, α-thujone, β-thujone, borneol, and viridiflorol, which are thought to mainly produce the biological effects of sage oil. Sage oil also contains flavonoids and polyphenolic compounds that mediate strong antioxidant, radical-scavenging, and antibacterial activities . It is found in cosmetics, personal care products and dietary supplements.

Categories:

Sage oil is categorized under the following therapeutic classes: Agents that reduce seizure threshold, Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic Extract. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Sage oil is a type of Anti-infective Agents


Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.